Empress Announces Formation of World Leading Scientific Advisory Board
23 Jan 2024 //
BUSINESSWIRE
Empress Therapeutics emerges with $50m to fund small molecule development
21 Jun 2023 //
PHARMACEUTICAL TECHNOLOGY
Flagship Pioneering Unveils Empress to Revolutionize Drug Discovery
21 Jun 2023 //
PR NEWSWIRE